📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Preclinical Evaluation of 177Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy. (2025)

First Author: Foxton C

Attributed to: Imaging DNA damage repair during radionuclide therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.124.268508

PubMed Identifier: 40049746

Publication URI: http://europepmc.org/abstract/MED/40049746

Type: Journal Article/Review

Parent Publication: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

ISSN: 0161-5505